Filter
474
Filtered Results: 474
Text search:
Artemisinin
Featured
Recommendations
34
New Publications
211
Language
Document type
No document type
317
Studies & Reports
66
Guidelines
45
Strategic & Response Plan
19
Manuals
11
Fact sheets
9
Training Material
3
Situation Updates
2
Resource Platforms
2
Countries / Regions
Kenya
24
Sierra Leone
23
Uganda
21
Liberia
21
Global
19
Senegal
17
Malawi
16
Tanzania
15
Rwanda
14
Nigeria
14
Myanmar / Burma
14
Ghana
13
Mozambique
13
India
13
Ethiopia
11
Zambia
10
Cameroon
9
Zimbabwe
9
Africa
8
Indonesia
8
Madagascar
8
Cambodia
7
South Africa
7
Nepal
6
Latin America and the Carribbean
6
Congo, Democratic Republic of
6
Bangladesh
6
Benin
4
Burkina Faso
4
South–East Asia Region
4
North America
4
Namibia
4
Guinea
3
Thailand
2
Philippines
2
Venezuela
2
Vietnam
2
Mali
2
Botswana
2
Somalia
2
Eswatini/ Swaziland
2
North Macedonia
1
Colombia
1
China
1
Laos
1
Haiti
1
Asia
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Paraguay
1
Turkmenistan
1
East and Southern Africa
1
Lebanon
1
Papua New Guinea
1
Brazil
1
Sudan
1
Angola
1
Authors & Publishers
Publication Years
Category
Countries
309
Clinical Guidelines
49
Public Health
38
Women & Child Health
11
Key Resources
9
Pharmacy & Technologies
7
Capacity Building
5
Toolboxes
Pharmacy
19
AMR
18
Malaria
14
NTDs
12
Health Financing Toolbox
8
Caregiver
6
Planetary Health
6
Global Health Education
6
HIV
5
COVID-19
5
TB
4
Ebola & Marburg
4
NCDs
2
Rapid Response
1
Conflict
1
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Conducted November 2011 to February 2012: Summary Report
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
This summary report has five sections. Following the introduction (Section 1), Section 2 sets out summary findings and recommendations of the assessment team. Section 3 describes the context in which artemisinin resistance is being tackle...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner drug ...
All malaria-endemic countries in the Region of the Americas have taken on the challenge of eliminating malaria and have focused their health programs and strategies on that goal. The risk of emergence of artemisinin resistance in the Americas, the characteristics of P. falciparum parasite, and the e...
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
In the context of the Support to National Malaria Control Programme (SuNMaP), demand creation is the strategic combination of advocacy, communication and mobilisation approaches that seek to achieve increased community awareness of, and demand for, effective malaria prevention and treatment services...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...
The World Health Organization's malaria fact sheet provides an overview of malaria, a life-threatening disease caused by Plasmodium parasites transmitted through the bites of infected female Anopheles mosquitoes. It highlights that malaria is preventable and curable, yet remains a significant glo...
The article "Malaria – MSD Manual Professional Edition" provides a comprehensive overview of malaria, an infection caused by Plasmodium species. It describes symptoms such as fever, chills, and anemia, explains diagnostic methods like parasite detection in blood smears, and discusses treatment opt...
Esta nota técnica busca guiar a los programas nacionales de malaria y a las organizaciones implicadas en el apoyo de los esfuerzos para la eliminación de la malaria en la Región de las Américas, a fin de que intensifiquen las acciones políticas/estratégicas e implementen los cambios operativos...
La Stratégie de riposte face à la résistance aux antipaludiques en Afrique est un document technique de sensibilisation qui se fonde sur les bases factuelles les plus solides dont on dispose et vise à réduire au maximum la menace et l’impact de la résistance aux antipaludiques de Plasmodium ...
Available in English, French and Spanish
Available in English, French and Spanish
A feasibility study in five African sites
This implementation plan sets out a series of programmatic objectives, activities and outcomes for malaria surveillance strengthening in Myanmar over the next two years. This period represents a key phase as the National Malaria Control Programme (NMCP) strives to build on recent achievements in str...
Accessed on 30.01.2020
Au Sénégal, la mortalité infanto-juvénile est surtout causée par le paludisme les maladies diarrhéiques et les infections respiratoires aigües (IRA). Des travaux ont montré que 80% des décès d’enfants de zéro à cinq ans (0 à 5 ans) surviennent dans les maisons ...
